Trials / Unknown
UnknownNCT05388747
Population Pharmacokinetics, Effectiveness and Safety of Cefuroxime in Neonates
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Shandong University · Academic / Other
- Sex
- All
- Age
- 0 Days – 28 Days
- Healthy volunteers
- Not accepted
Summary
Cefuroxime is a time-dependent antibiotic that is used to treat bacterial infections. However, population pharmacokinetic，effectiveness and safety data for cefuroxime in neonates are lacking. The aim of this study was to assess the population pharmacokinetics, effectiveness, and safety of cefuroxime in neonates.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cefuroxime | Population pharmacokinetics, effectiveness, and safety of cefuroxime |
Timeline
- Start date
- 2022-05-16
- Primary completion
- 2025-07-01
- Completion
- 2025-12-01
- First posted
- 2022-05-24
- Last updated
- 2022-05-24
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05388747. Inclusion in this directory is not an endorsement.